Prospective observational registry (n=1000) collecting biomarker and clinical outcome data from patients receiving ECT, TMS/dTMS, racemic ketamine infusions, or intranasal esketamine for treatment‑resistant depression and OCD.
The University of Iowa Interventional Psychiatry Service Patient Registry prospectively collects clinical, neuroimaging, EEG, cognitive, vocal, autonomic, and genetic/epigenetic data from patients undergoing procedural treatments for treatment‑resistant depression and OCD.
Analyses will seek multimodal biomarkers predictive of treatment response and compare within‑subject and between‑modality changes (e.g., ECT vs TMS vs ketamine) to inform precision treatment selection.
Prospective observational cohort capturing clinical and biomarker data across procedural treatments (ECT, TMS/dTMS, racemic ketamine infusion, intranasal esketamine).
Electroconvulsive therapy (ECT) device procedure captured as part of registry
Transcranial Magnetic Stimulation (TMS) device procedure captured; includes deep TMS (dTMS) for OCD
Racemic ketamine infusion (clinical dosing) captured
Intranasal esketamine insufflation captured
Other device-based procedural treatments as appropriate